Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter, Exploratory Phase IIa Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 Administered for 12 Weeks in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Next Previous
Search
Trial Profile

Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter, Exploratory Phase IIa Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 Administered for 12 Weeks in Subjects with Idiopathic Pulmonary Fibrosis (IPF)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ziritaxestat (Primary)
  • Indications Idiopathic pulmonary fibrosis
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics; Proof of concept
  • Acronyms FLORA
  • Sponsors Galapagos NV

    • Most Recent Events

    • 06 Apr 2019 Results evaluating exposure response relationship of GLPG 1690 and further develop a rational basis to support dose selection for clinical trials in patients with idiopathic pulmonary fibrosis published in the Clinical Pharmacokinetics
    • 23 May 2018 Results assessing the effects of GLPG1690 in IPF using Functional Respiratory Imaging (n=18), presented at the 114th International Conference of the American Thoracic Society
    • 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top